x

Rechercher un projet de recherche

* (*) Champ obligatoire

64 Résultat(s)

Trier par

Financé par un membre IRDiRC =

Projets de recherche

ALLEMAGNE

Bayern
MARTINSRIED

Cellular Toxicity of Polyglutamine Proteins in Neurodegenerative Disease
Max-Planck-Institut für Biochemie
Abteilung zelluläre Biochemie

PORTUGAL

NORTE
PORTO

CACNA1A gene involvement in cognition and synaptic function in calcium channel disease.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Search for disease modifiers in spinocerebellar ataxias: human and animal-based approaches.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

ROYAUME-UNI

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Sobell Department of Motor Neuroscience and Movement Disorders

ROYAUME-UNI

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

ALLEMAGNE

Schleswig-Holstein
LÜBECK

Phenotypic spectrum and molecular characterization of Movement disorders
Universität Lübeck
Institut für Neurogenetik

FRANCE

ILE-DE-FRANCE
PARIS

Financé par un membre IRDiRCSPATAX-QUEST: Identification de nouveaux gènes de dégénérescences spinocérébelleuses par une combinaison d'analyse de liaison, de séquençage nouvelle génération et de validation biologique in vitro et in vivo
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIE

LAZIO
ROMA

SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare

ITALIE

PIEMONTE
TORINO

Identification of the gene responsible for a novel form of autosomal dominant spinocerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva

PORTUGAL

NORTE
PORTO

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
SANTA MARIA DA FEIRA

ROYAUME-UNI

Berkshire
READING

ROYAUME-UNI

Greater London
LONDON

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma

ROYAUME-UNI

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
Great Ormond Street Hospital for Children, NHS Foundation Trust
Department of Chemical Pathology

ROYAUME-UNI

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

ROYAUME-UNI

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
UCL Institute of Child Health, University College London
Metabolic Unit

ROYAUME-UNI

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium

ROYAUME-UNI

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre

ROYAUME-UNI

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Department of Clinical Genetics

ROYAUME-UNI

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Oxford Medical Genetics Laboratories

ROYAUME-UNI

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme

ROYAUME-UNI

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit

ALLEMAGNE

Baden-Württemberg
TÜBINGEN

Financé par un membre IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik

ALLEMAGNE

Nordrhein-Westfalen
BONN

ALLEMAGNE

Nordrhein-Westfalen
KÖLN

Financé par un membre IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik

ETATS-UNIS

Arizona
PHOENIX

Financé par un membre IRDiRCThe etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute

FRANCE

ILE-DE-FRANCE
PARIS

Financé par un membre IRDiRCNeuromics: Projet de recherche européen intégré pour le diagnostic et la thérapie dans les maladies neuromusculaires et neurodégénératives rares - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIE

LOMBARDIA
MILANO

Financé par un membre IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali

ROYAUME-UNI

Greater Manchester
ADDRESS: NOT PROVIDED - UK

ROYAUME-UNI

Lothian
EDINBURGH

Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit

ROYAUME-UNI

Oxfordshire
OXFORD

ALLEMAGNE

Bayern
MÜNCHEN

Financé par un membre IRDiRCRHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie

FRANCE

ILE-DE-FRANCE
PARIS

Financé par un membre IRDiRCSTaHR : Stimulation de la Recombinaison Homologue pour la Thérapie Génique - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FRANCE

PAYS DE LA LOIRE
NANTES

Financé par un membre IRDiRCFROGH : Etude Génétique de la Population Française - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

ITALIE

CAMPANIA
NAPOLI

Financé par un membre IRDiRCTelethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine

Projets de recherche multicentriques